Research Topics
| B DiamondSummaryAffiliation: North Shore University Hospital Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Losing your nerves? Maybe it's the antibodiesBetty Diamond
The Feinstein Institute for Medical Research, Center of Autoimmune and Musculoskeletal Diseases, 350 Community Drive, Manhasset, New York 110301, USA
Nat Rev Immunol 9:449-56. 2009..Under conditions of BBB compromise, and during fetal development, we think that these antibodies can alter brain function in otherwise healthy individuals...
Brain-reactive antibodies and diseaseB Diamond
Feinstein Institute for Medical Research, Manhasset, New York 11030, USA
Annu Rev Immunol 31:345-85. 2013....
A model for lupus brain diseaseBetty Diamond
Center for Autoimmune and Musculoskeletal Diseases, The Feinstein Institute for Medical Research, North Shore Long Island Jewish Health System, Manhasset, NY 11030, USA
Immunol Rev 248:56-67. 2012..We discuss the implications of this model for lupus and for identifying other antibodies that may contribute to brain disease...
It takes guts to grow a brain: Increasing evidence of the important role of the intestinal microflora in neuro- and immune-modulatory functions during development and adulthoodBetty Diamond
Center for Autoimmune and Musculoskeletal Diseases, The Feinstein Institute for Medical Research, North Shore Long Island Jewish Health System, Manhasset, NY, USA
Bioessays 33:588-91. 2011..These observations necessitate a new look at the many interconnections of the immune system and the brain, suggesting new frontiers for research and new therapeutic strategies for neurodevelopmental diseases...
Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosusB Diamond
Autoimmune and Musculoskeletal Disease Center, The Feinstein Institute for Medical Research, Manhasset, NY 11030, USA
J Intern Med 269:36-44. 2011..Thus, it might be possible to treat the aspects of autoimmune disease without inducing major immunosuppression and ensuing infectious complications...
[Neuropsychiatric lupus and autoantibodies against ionotropic glutamate receptor (NMDAR)]J F G Cohen-Solal
Center for Autoimmune and Musculoskeletal Disorders, The Feinstein Institute for Medical Research NS LIJ, 350, Community Drive, Manhasset, NY 11030, USA
Rev Med Interne 32:130-2. 2011..In conclusion, the serum titer of autoantibodies against NR2A/B subunits is an indication of the potential for neuropsychiatric manifestations during the course of the disease...
Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosusCynthia Aranow
Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA
Rheum Dis Clin North Am 36:187-201, x-xi. 2010..These studies suggest that an anatomic classification scheme for neuropsychiatric SLE may facilitate research on etiopathogenesis and the design of clinical trials...
Pathogenic autoantibodies in systemic lupus erythematosus are derived from both self-reactive and non-self-reactive B cellsJie Zhang
The Center for Autoimmune and Musculoskeletal Disease, Feinstein Institute for Medical Research, North Shore LIJ Health System, Manhasset, New York 11030, USA
Mol Med 14:675-81. 2008..Moreover, ineffective tolerance checkpoints may exist before and after antigen activation in SLE...
The role of B cells in lupus pathogenesisEmil Nashi
The Center for Autoimmune and Musculoskeletal Disease, The Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030, United States
Int J Biochem Cell Biol 42:543-50. 2010..Moreover, we discuss how B cell survival and maturation are regulated centrally prior to antigen activation and in the periphery after antigen activation to form the repertoire that generates the spectrum of circulating antibodies...
Phenotypic characterization of autoreactive B cells--checkpoints of B cell tolerance in patients with systemic lupus erythematosusAnnett M Jacobi
The Center for Autoimmune and Musculoskeletal Diseases, Feinstein Institute for Medical Research, North Shore Long Island Jewish Health System, Manhasset, New York, USA
PLoS ONE 4:e5776. 2009..This methodology enables us to gain insight into the development and fate of DNA-reactive B cells in individual patients with SLE and paves the way ultimately to permit better and more customized therapies...
Enhanced selection of high affinity DNA-reactive B cells following cyclophosphamide treatment in miceDaisuke Kawabata
Center for Autoimmune and Musculoskeletal Disease, The Feinstein Institute for Medical Research, Manhasset, New York, United States of America
PLoS ONE 5:e8418. 2010..There are significant implications for therapy...
Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potentialJie Zhang
The Center for Autoimmune and Musculoskeletal Disease, Feinstein Institute for Medical Research, North Shore Long Island Jewish Health System, 350 Community Drive, Manhasset, NY 11030, USA
J Autoimmun 33:270-4. 2009..Thus, the IgM polyreactive repertoire in SLE includes antibodies that may acquire pathogenic function merely by undergoing class-switch recombination to become IgG antibodies...
Selective regulation of autoreactive B cells by FcgammaRIIBJeganathan Venkatesh
Center for Autoimmune and Musculoskeletal Disease, The Feinstein Institute for Medical Research, Manhasset, NY 11030, USA
J Autoimmun 32:149-57. 2009..These data demonstrate that FcgammaRIIB preferentially limits activation of high affinity autoreactive B cells and can influence the activation of DC through an immune complex-mediated mechanism...
Increased IL-12 inhibits B cells' differentiation to germinal center cells and promotes differentiation to short-lived plasmablastsSun Jung Kim
Autoimmune Disease Laboratory, Feinstein Institute for Medical Research, Manhasset, NY 11030, USA
J Exp Med 205:2437-48. 2008..Understanding the factors that regulate antigen-activated B cell differentiation and memory cell formation has implications for both antibody-mediated autoimmune disease and protective antibody responses...
Identification of DNA-reactive B cells in patients with systemic lupus erythematosusJie Zhang
Feinstein Institute for Medical Research, North Shore Long Island Jewish Health System, Manhasset, New York 11030, USA
J Immunol Methods 338:79-84. 2008..This methodology enables us to track the development of autoreactive B cells, which recognize peptide and dsDNA, in individual patients with SLE and permits the isolation of autoreactive B cells for further characterization...
Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging studyAnnett M Jacobi
Feinstein Institute for Medical Research, Manhasset, New York 11030, USA
Arthritis Rheum 62:201-10. 2010..To understand the effects of long-term BLyS inhibition in human systemic lupus erythematosus (SLE)...
Research Grants
- Studies of Human and Murine SLEBetty Diamond; Fiscal Year: 2006..This effort is based on already existing interactions among the investigators and will be substantially strengthened by the resources provided by the Program Project...
- Antibodies to NR2 in SLEBetty Diamond; Fiscal Year: 2006..I.: Michael Lockshin). The overall goal of this collaborative interactive program is to develop the scientific foundation for preventative therapies for cognitive decline in SLE. ..
- AUTOIMMUNITY CENTERS OF EXCELLENCEBetty Diamond; Fiscal Year: 2007..Finally, the Center will include an administrative core for coordination and implementation of Center activities. ..
- Understanding the SELENA trial: Estrogen in LupusBetty Diamond; Fiscal Year: 2007..It cannot be emphasized too much that this study can be performed only in the cohort of patients in the SELENA trial. Another such study will not be performed. ..
- Anti-Microbial Antibodies Induce Neuropsychiatric SyndromesBetty Diamond; Fiscal Year: 2007..Expertise in immunology, neurology and neuroscience are all critical to this proposal. If this model can be validated, novel approaches to preventing neuropsychiatric symptoms that occur following trauma could be explored. ..
- Antibodies to NR2 in SLEBetty Diamond; Fiscal Year: 2007..This application represents a multidisciplinary approach to build on a novel model for neuropsychiatric manifestations of lupus and a novel paradigm for antibody-mediated changes in cognition and behavior. ..
- An antigen induced model of SLEBetty Diamond; Fiscal Year: 2005..We will determine if an enhanced T cell response alters the repertoire of activated B cells. These studies, in composite, will help us understand how autoreactive B cells can be activated in vivo by antigen exposure. ..
- Antibodies to NR2 in SLEBetty Diamond; Fiscal Year: 2009..This application represents a multidisciplinary approach to build on a novel model for neuropsychiatric manifestations of lupus and a novel paradigm for antibody-mediated changes in cognition and behavior. ..
- Anti-Microbial Antibodies Induce Neuropsychiatric SyndromesBetty Diamond; Fiscal Year: 2010..Expertise in immunology, neurology and neuroscience are all critical to this proposal. If this model can be validated, novel approaches to preventing neuropsychiatric symptoms that occur following trauma could be explored. ..
- Antibodies to NR2 in SLEBetty Diamond; Fiscal Year: 2010..This application represents a multidisciplinary approach to build on a novel model for neuropsychiatric manifestations of lupus and a novel paradigm for antibody-mediated changes in cognition and behavior. ..
- Instrumentation Grant FACSVantageBetty Diamond; Fiscal Year: 2002..abstract_text> ..
- FASEB Research Conference on: AutoimmunityBetty Diamond; Fiscal Year: 2004..Many investigators consider it to be the premier meeting on autoimmunity. ..
- Antibodies to NR2 in SLEBetty Diamond; Fiscal Year: 2004..Ultimately, we hope to develop the scientific foundation for a clinical trial of NR2 receptor antagonists to protect against cognitive decline in SLE. ..
- Sex-based Differences in the Immune ResponseBetty Diamond; Fiscal Year: 2005..Finally, we will investigate the differences in B cell responsiveness to estrogen in BALB/c and C57Bl/6 mice to understand what underlies an estrogen mediated breakdown in humoral self- tolerance. ..
- Toward a new approach to SLE therapyBetty Diamond; Fiscal Year: 2010..PUBLIC HEALTH RELEVANCE: This proposal identifies a non-immunosuppressive strategy for the treatment of systemic lupus. ..
